US2005220719A1PendingUtilityA1

Nasal passage cleaning composition

Individually held — no corporate assignee on recordPriority: Aug 6, 2001Filed: May 24, 2005Published: Oct 6, 2005
Est. expiryAug 6, 2021(expired)· nominal 20-yr term from priority
A61K 33/32A61K 45/06
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A nasal passage cleaning composition comprises a saline base and contains non-steroidal natural ingredients at a buffeted comfortable pH. The composition cleans and clears the nasal passages and relieves pain, with limited irritation and substantially no side effects.

Claims

exact text as granted — not AI-modified
1 . A non steroidal nasal passage clearing composition comprising a mixture containing a salt and water solution, an antiseptic, an analgesic, a decongestant, a moisturizer and a non-steroidal anti-inflammatory, formulated as a liquid for dispensing in the nasal passage.  
   
   
       2 . The composition of  claim 1  wherein the antiseptic is selected from the group consisting of tea tree oil, camphor, glycerine, zinc sulfate and combinations thereof.  
   
   
       3 . The composition of  claim 1  further comprising an astringent selected from the group consisting of potassium alum, zinc sulfate, tannic acid or combinations thereof.  
   
   
       4 . The composition of  claim 1  wherein the antipruritic analgesic is selected from the group consisting of methyl salicylate, camphor, and combinations thereof.  
   
   
       5 . The composition of  claim 1  wherein the moisturizer is selected from the group consisting of glycerine, balsam tolu (gum benzoin), tea tree oil and combinations thereof.  
   
   
       6 . The composition of  claim 1  further comprising an aromatizer selected from the group consisting of tea tree oil, camphor, menthol, peppermint oil, and combinations thereof.  
   
   
       7 . The composition of  claim 1  wherein the non-steroidal anti-inflammatory is selected from the group consisting of methyl salicylate, zinc sulfate, and combinations thereof.  
   
   
       8 . A non-steroidal nasal passage clearing composition consisting essentially of a salt and water solution containing an antiseptic selected from the group consisting of tea tree oil, camphor, zinc sulphate and combinations thereof, present at from 0.1 to 2 grams per liter, an analgesic selected from the group consisting of salicylic acid derivatives, methyl salicylate, propionic acid derivatives, camphor and combinations thereof, present at from 0.01 to 0.1 grams per liter, a mucolytic selected from the group consisting of n-acetyl L-cystine, bromhexine, guaifenesin, mucolytic enzymes and combinations thereof, present at from 0.1 to 3 grams per liter, a moisturizer selected from the group consisting of glycerin, balsam tolu (gum benzoin), tea tree oil, and combinations thereof, present at from at least 0.01 to 0.1 grams per liter, a non-steroidal anti-inflammatory from the group consisting of zinc compounds such as zinc sulfate present at from 0.1 to 3 grams per liter, a salicylic acid derivative or propionic acid derivative present at from 0.1 to 2 ml. per liter and combinations thereof, the composition being a sprayable liquid having a comfortable pH for rinsing the nasal passage.  
   
   
       9 . The non-steroidal nasal passage clearing composition of  claim 8  wherein the composition contains zinc sulfate between 0.1 and 3 grams per liter, glycerin at 5 to 50 grams per liter, gum benzoin, at least 0.1 to 3 g/liter camphor between 0.1 and 3 grams per liter, and further comprising aloe between 0.4 and 4 grams per liter, alcohol between 0.5 and 3 ml per liter and tea tree oil and methyl salicylate between 0.1 and 2 ml. per liter.  
   
   
       10 . The non-steroidal nasal passage clearing composition of  claim 8  further comprising an ingredient selected from the group consisting of peppermint oil, thymol, eucolyptol, cinnamon, aloe, pine oil, spearmint oil, benzalkonium chloride and combinations thereof.  
   
   
       11 . A method for clearing the nasal passages comprising providing a non-steroidal nasal passage clearing composition consisting of a salt and water base and containing an antiseptic selected from the group consisting of tea tree oil, camphor, glycerine, alcohol, zinc sulfate and combinations thereof, present at from 0.1 to 2 grams per liter, an analgesic selected from the group consisting of methyl salicylate, camphor and combinations thereof, present at from 0.01 to 0.1 grams per liter, a mucolytic selected from the group consisting of n-acetyl L-cystine, guaifenasin, mucolytic enzymes and combinations thereof, present at from 0.1 to 3 grams per liter, a moisturizer selected from the group consisting of glycerin, balsam tolu/gum benzoin, tea tree oil, and combinations thereof, present at from 0.01 to 0.1 grams per liter, a non-steroidal anti-inflammatory from the group consisting of zinc sulfate present at from 0.1 to 3 grams per liter, methyl salicylate present at from 0.1 to 2 ml per liter, and combinations thereof, the composition being a liquid having a comfortable pH for rinsing the nasal passage; and, spraying the nasal passages with the liquid composition.  
   
   
       12 . A method of clearing the nasal passages comprising applying a composition having a salt and water base, and a mucolytic agent (n-acetyl-L-cystine) and methyl salicylate, an antiseptic, an analgesic, a decongestant, a moisturizer and a non-steroidal anti-inflammatory to the nasal passages.  
   
   
       13 . The method of  claim 12  wherein the composition is applied by spraying, dropping or douching the nasal passages.  
   
   
       14 . The method of  claim 11  further comprising providing an astringent selected from the group consisting of potassium alum, zinc sulfate and combinations thereof for shrinking the nasal passage and easing breathing and to help stop any bleeding of the nose.  
   
   
       15 . The method of  claim 12  further comprising providing an astringent selected from the group consisting of potassium alum, zinc sulfate and combinations thereof for shrinking the nasal passage and easing breathing and to help stop any bleeding of the nose.

Join the waitlist — get patent alerts

Track US2005220719A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.